Lenalidomide - CAS 191732-72-6
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C13H13N3O3
Molecular Weight:
259.265
COA:
Inquire
Targets:
PROTAC | TNF-alpha
Description:
Lenalidomide is an analog of thalidomide, a TNF-α production inhibitor. Lenalidomide can be utilized in PROTAC as an E3 ligase ligand for targeting cereblon, inducing ubiquitination and degradation of casein kinase (CK) 1α by E3 ubiquitin ligase. Lenalidomide has been developed for the treatment of multiple myeloma and myelodysplastic syndromes (MDS).
Purity:
≥98%
Appearance:
Off-white Solid
Synonyms:
3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione; 3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione
Storage:
-20°C
MSDS:
Inquire
Shelf Life:
2 years
Melting Point:
>250ºC (dec.)
InChIKey:
GOTYRUGSSMKFNF-UHFFFAOYSA-N
InChI:
InChI=1S/C13H13N3O3/c14-9-3-1-2-7-8(9)6-16(13(7)19)10-4-5-11(17)15-12(10)18/h1-3,10H,4-6,14H2,(H,15,17,18)
Canonical SMILES:
C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N
1.Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.
Moreau P, Masszi T, Grzasko N, Bahlis NJ, Hansson M, Pour L, Sandhu I, Ganly P, Baker BW, Jackson SR, Stoppa AM, Simpson DR, Gimsing P, Palumbo A, Garderet L, Cavo M, Kumar S, Touzeau C, Buadi FK, Laubach JP, Berg DT, Lin J, Di Bacco A, Hui AM, van de Vel N Engl J Med. 2016 Apr 28;374(17):1621-34. doi: 10.1056/NEJMoa1516282.
BACKGROUND: Ixazomib is an oral proteasome inhibitor that is currently being studied for the treatment of multiple myeloma.
2.A study of high-dose lenalidomide induction and low-dose lenalidomide maintenance therapy for patients with hypomethylating agent refractory myelodysplastic syndrome.
Cherian MA1, Tibes R2, Gao F3, Fletcher T1, Fiala M1, Uy GL1, Westervelt P1, Jacoby MA1, Cashen AF1, Stockerl-Goldstein K1, DiPersio JF1, Vij R1. Leuk Lymphoma. 2016 Apr 27:1-6. [Epub ahead of print]
Myelodysplastic syndromes (MDS) are clonal hematopoietic disorders characterized by bone marrow failure which frequently progress to acute myeloid leukemia. Patients who fail to respond to, or progress on first-line DNA hypomethylating agents (HMA) have a poor prognosis. Conventionally dosed lenalidomide has activity in 5q-MDS. In other subtypes, it may reduce RBC transfusion requirements but does not result in cytogenetic responses. We previously reported that high-dose lenalidomide induction (50 mg/day) results in complete remissions in a high fraction of patients. We, therefore, conducted a Phase 2 trial of the same regimen in MDS refractory to HMA. Marrow complete remissions were seen in 33% of patients and hematological improvement in 8% of patients. Significant infections complicated more than 50% of cases. Future trials to explore alternative dosing schedules of high-dose lenalidomide to increase efficacy while decreasing toxicity are warranted.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related PROTAC Products


CAS 2250025-90-0 TL 13-27

TL 13-27
(CAS: 2250025-90-0)

TL 13-27 is a negative control of TL 12-186.

CAS 13419-46-0 DCVC

DCVC
(CAS: 13419-46-0)

DCVC has been found to influence sort of cytokines release stimulated by pathogen.

Pomalidomide-C6-PEG3-butyl azide

Pomalidomide-C6-PEG3-butyl azide is a crosslinker-E3 ligase ligand conjugate consisting of an E3 ligase ligand pomalidomide and a PEGylated crosslinker with ter...

CAS 1835705-72-0 Pomalidomide-PEG2-butyl iodide

Pomalidomide-PEG2-butyl iodide
(CAS: 1835705-72-0)

Pomalidomide-PEG2-butyl iodide is a crosslinker-E3 ligase ligand conjugate consisting of an E3 ligase ligand pomalidomide and a PEGylated crosslinker with termi...

CAS 1243329-97-6 Lenalidomide hydrochloride

Lenalidomide hydrochloride
(CAS: 1243329-97-6)

Lenalidomideis a derivative of thalidomide introduced in 2004. Lenalidomide (Revlimid, CC-5013) is a TNF-α secretion inhibitor with IC50 of 13 nM.

BMS561392
(CAS: 611227-74-8)

BMS561392 is a tumor necrosis factor-alpha (TNF alpha) converting enzyme inhibitor. It has the potential treatment of diseases characterized by overproduction o...

CAS 4311-88-0 Necrostatin-1

Necrostatin-1
(CAS: 4311-88-0)

Necrostatin-1 is a specific RIP1 inhibitor and inhibits TNF-α-induced necroptosis with EC50 of 490 nM.

(S,R,S)-AHPC-C6-CO2H hydrochloride

(S,R,S)-AHPC-C6-CO2H hydrochloride is a crosslinker−E3 ligase ligand conjugate consisting of a von Hippel-Lindau (VHL)-recruiting ligand and an alkyl chain link...

CAS 852391-15-2 Necrostatin 2 racemate

Necrostatin 2 racemate
(CAS: 852391-15-2)

Necrostatin 2 racemate is the racemate of Necrostatin, which is a potent necroptosis inhibitor.

CAS 2010159-45-0 (S,R,S)-AHPC-PEG2-azide

(S,R,S)-AHPC-PEG2-azide
(CAS: 2010159-45-0)

(S,R,S)-AHPC-PEG2-azide is a crosslinker−E3 ligase ligand conjugate consisting of a von Hippel-Lindau (VHL)-recruiting ligand and a PEGylated crosslinker with t...

CAS 528-43-8 Magnolol

Magnolol
(CAS: 528-43-8)

Magnolol is a bioactive lignin found in Magnolia officinalis and acts as a TNF-α and nitric oxide (NO) inhibitor. It exhibits potential therapeutic effect on an...

CAS 186763-78-0 Ginsenoside Rg5

Ginsenoside Rg5
(CAS: 186763-78-0)

Ginsenoside Rg5, a main constituent isolated from red ginseng, exhibits anti-inflammatory property as in LPS-stimulated alveolar macrophages it inhibited the ex...

CAS 852391-19-6 Necrostatin 2

Necrostatin 2
(CAS: 852391-19-6)

Necrostatin 2 is a potent necroptosis inhibitor. It is a potent in vitro necroptosis inhibitors and is also efficacious in an animal model of ischemic stroke.

CAS 5786-54-9 Hispidol

Hispidol
(CAS: 5786-54-9)

Hispidol ((Z)-Hispidol) inhibits TNF-α induced adhesion of monocytes to colon epithelial cells (IC50= 0.50 µM) and is a potential therapeutic for inflammatory b...

CAS 332420-90-3 C 87

C 87
(CAS: 332420-90-3)

C 87 is a TNF-α inhibitor (Kd = 110 nM for hTNF-α). It was shown to inhibit TNF-α-induced cytotoxicity in L929 fibroblast cells, attenuate inflammation and incr...

CAS 2138440-81-8 Pomalidomide-PEG4-CO2H

Pomalidomide-PEG4-CO2H
(CAS: 2138440-81-8)

Pomalidomide-PEG4-CO2H is a crosslinker-E3 ligase ligand conjugate consisting of an E3 ligase ligand pomalidomide and a PEGylated crosslinker with terminal carb...

CAS 2250025-88-6 TL 12-186

TL 12-186
(CAS: 2250025-88-6)

TL 12-186 is a multikinase degrading PROTAC consisting of a kinase inhibitor conjugated to the cereblon E3 ubiquitin ligase ligand pomalidomide.

Pomalidomide-C3-CO2H

Pomalidomide-C3-CO2H is a crosslinker-E3 ligase ligand conjugate consisting of an E3 ligase ligand pomalidomide and a short alkyl chain linker. It has been used...

CAS 1448189-80-7 Protein degrader 1 hydrochloride

Protein degrader 1 hydrochloride
(CAS: 1448189-80-7)

Protein degrader 1 hydrochloride is a building block used in the synthesis of PROTAC for the recruitment of the von Hippel-Lindau (VHL) protein.

Protac-1

Protac-1 is composed of the IκBα phosphopeptide that is recognized by the F-box protein β-TRCP, and ovalicin. MetAP-2 can be tethered to SCFβ-TRCP, ubiquitinate...

Chemical Structure

CAS 191732-72-6 Lenalidomide

Quick Inquiry

Verification code

Featured Items